HemOnc & COVID-19 Session with Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis
VJHEMONC
America/Argentina/Buenos_Aires GMT-3
Description
In this session, Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis will discuss and debate the special considerations for managing patients with hematological malignancies in the COVID-19 era.
The topics for discussion include the recommendations made in a recent publication they co-authored in Lancet Haematology:
• Reducing nosocomial COVID-19 infections and resource allocation
• Clinical trial participation
• Treating patients with ALL, CML, MPNs, MDS and AML
This session will be made available on-demand on VJHemOnc.com after the event to all those who have registered.
Inglês
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Speakers
Amer Zeidan, John Mascarenhas, Jan Bewersdorf, Rory Shallis
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.